NasdaqGS - Nasdaq Real Time Price • USD
Anika Therapeutics, Inc. (ANIK)
As of 10:57 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 3 |
| Avg. Estimate | -0.11 | 0.09 | 0 | -0.05 |
| Low Estimate | -0.19 | 0 | -0.2 | -0.47 |
| High Estimate | -0.03 | 0.18 | 0.21 | 0.33 |
| Year Ago EPS | -0.71 | -0.19 | -5.64 | 0 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 39.21M | 43.17M | 170.41M | 179.24M |
| Low Estimate | 39.2M | 41.24M | 169.82M | 179.18M |
| High Estimate | 39.23M | 45.1M | 171M | 179.3M |
| Year Ago Sales | 37.92M | 40.56M | 166.66M | 170.41M |
| Sales Growth (year/est) | 3.40% | 6.40% | 2.20% | 5.20% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.3 | -0.27 | -0.37 | -0.26 |
| EPS Actual | -0.71 | -0.19 | -0.45 | -4.3 |
| Difference | -0.41 | 0.08 | -0.08 | -4.04 |
| Surprise % | -136.70% | 29.60% | -21.60% | -1,553.80% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.11 | 0.09 | 0 | -0.05 |
| 7 Days Ago | -0.11 | 0.09 | 0 | -0.05 |
| 30 Days Ago | -0.11 | 0.09 | 0 | -0.05 |
| 60 Days Ago | -0.22 | -0.1 | -0.31 | 0.21 |
| 90 Days Ago | -0.22 | -0.1 | -0.31 | 0.21 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ANIK | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 84.50% | -- | -- | 1.50% |
| Next Qtr. | 147.40% | -- | -- | 11.40% |
| Current Year | 100.00% | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | 10.00% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -43.92% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Barrington Research: Outperform to Outperform | 3/14/2024 |
| Reiterates | Stephens & Co.: Equal-Weight to Equal-Weight | 3/14/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 1/3/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 11/3/2023 |
| Upgrade | Barrington Research: Market Perform to Outperform | 8/14/2023 |
| Maintains | Stephens & Co.: Equal-Weight to Equal-Weight | 8/10/2023 |
Related Tickers
ANGO AngioDynamics, Inc.
5.78
-1.53%
UTMD Utah Medical Products, Inc.
66.65
-0.76%
AZTA Azenta, Inc.
50.97
-2.16%
OSUR OraSure Technologies, Inc.
5.31
-3.55%
BLFS BioLife Solutions, Inc.
16.52
-3.93%
TFX Teleflex Incorporated
205.95
-2.47%
NVST Envista Holdings Corporation
19.96
-1.58%
ATRI Atrion Corporation
412.86
-2.67%
INFU InfuSystem Holdings, Inc.
7.71
-2.03%
MMSI Merit Medical Systems, Inc.
73.09
-1.27%